Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Remote monitoring for chronic pain using a smartphone app

Official title: Optimizing Chronic Pain Management Through Remote Monitoring: A Proof-of-Concept Study Using a Digital Platform

Run by Hackensack Meridian Health · NCT07837102 · Data updated 2026-11-12

This study tests a smartphone-based remote monitoring program to see if it improves health outcomes for adults with chronic pain.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorHackensack Meridian Health
Academic / other
Locations2 sites (Hackensack, New Jersey and 1 other locations)
StatusRecruiting
StartedDecember 18, 2025
Main results expectedFebruary 10, 2028
Study endsFebruary 10, 2028
Registry record updatedSeptember 23, 2026
Trial IDNCT07837102 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with a confirmed chronic pain syndrome (including fibromyalgia, back pain, neck pain, or joint pain) who own a smartphone, can access the FitCam app, and meet the study criteria.

Probably not a fit

Patients without access to a compatible smartphone or those who do not benefit from remote monitoring may not experience improvement.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-site, early feasibility study in adults with chronic pain using a digital platform for remote monitoring. It is a prospective, single-arm, interventional study with 100 planned enrollees and up to six months of follow-up after enrollment, using a convenience sample of 50 participants for the remote monitoring program over 3 to 6 months. The intervention centers on the FitCam portal/app to track health metrics and activity, with outcomes compared to baseline health quality. The study aims to observe whether remote monitoring can influence pain-related health outcomes over time, within a 12-month conduct window. The trial will be conducted at Hackensack Meridian Health facilities in Paramus and Hackensack, NJ.

Why it matters

Potential benefit: If successful, participants could experience improved pain management and quality of life through enhanced remote support and monitoring.

How similar studies have gone: Prior studies of remote monitoring in chronic conditions have shown mixed to positive results; this study explores feasibility and potential impact in chronic pain using a smartphone-based platform.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Signed informed consent form (ICF)
* Age: Adults aged 18 years or older
* Ability to comply with the study protocol, including having a smartphone and being able and willing to access the application on a regular basis. To use all functionalities of the application, the user's smartphone must comply with the minimum system requirements (Android version 8.0 or above, iOS version 13.0 or above)
* Have a valid email address
* Have a valid phone number
* Diagnosis Codes:

  * Patients with a confirmed diagnosis of Chronic Pain Syndrome based on ICD-10 code G89.4 as primary diagnosis.

    ■ Including Fibromyalgia M79.7
  * Patient with a confirmed secondary diagnosis

    * Back Pain M54.5
    * Neck Pain M54.2
    * Joint Pain M25.5
* Medications: N/A
* Test/Lab results: N/A
* Study sites: Hackensack Meridian Health Neuroscience Institute located at 650 From Road, Suite 506, Paramus, NJ, 07652
* Service: Outpatient

Exclusion Criteria:

* Age: Patients below 18 years of age
* Unable or unwilling to provide informed consent
* Presence of an active diagnosis of a comorbid cognitive impairment such as dementia or mild cognitive impairment
* Lack of access to a smartphone device or inability to demonstrate proficiency in downloading and using mobile applications
* Physical limitations that prevent participation in a basic home exercise program
* Considered by the investigator to have a condition that precludes safe or active participation in the trial

Where it's running

  • Hackensack University Medical Center
    Hackensack, New Jersey, United States
    Recruiting
  • Hackensack Meridian Health Neuroscience Institute
    Paramus, New Jersey, United States
    Recruiting

Study contacts

  • Principal investigator: Jacob Hascalovici, MD — Hackensack Meridian Health
  • Study coordinator: Akash Gujral
  • Email: akash.gujral@hmhn.org
  • Phone: 5519968100

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work

    This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.

    Recruiting at 2 sites Karolinska Institutet · Luleå, Norrbotten County and 2 other locations · NCT07924774

  • One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital

    A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.

    Recruiting Ottawa Hospital Research Institute · Ottawa, Ontario · NCT07919626

  • Meaning-Based Psychotherapy for Adults with Chronic Pain

    This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.

    Recruiting Hospital Clinico Universitario San Cecilio · Granada, Granada · NCT07915440

  • How chronic pain changes over time in kids with Duchenne Muscular Dystrophy

    This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.

    Recruiting Antalya Training and Research Hospital · Antalya, Antalya · NCT07892196

  • CBD for Opioid Dependence and Pain on Buprenorphine

    This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.

    Recruiting Early Phase 1 Yale University · West Haven, Connecticut · NCT07886606

  • Cebranopadol for opioid withdrawal in adults with chronic pain

    This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.

    Recruiting at 2 sites Phase 2 Adneuris Therapeutics, Inc. · North Canton, Ohio and 1 other locations · NCT07874620

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.